Irene Thiel
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer survivorship and care
- HER2/EGFR in Cancer Research
Papers in
-
- Ovarian cancer diagnosis and treatment 2
- Oncology 3
- Cancer survivorship and care 2
- Co-authors
- Florentia Peintinger (2 shared papers)Elfriede Greimel (2 shared papers)Edgar Petru (2 shared papers)Herman Einsele (1 shared paper)Carsten Bokemeyer (1 shared paper)Lothar Kanz (1 shared paper)Hans‐Joachim Schmoll (1 shared paper)
- Journals
- International Journal of Gynecological Cancer (2 papers)Annals of Oncology (1 paper)The Lancet Oncology (1 paper)Oncology Reports (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- Austria
In The Last Decade
Irene Thiel
6 papers receiving 514 citations
Irene Thiel's Hit Papers
Peers
Comparison fields: 5 of 53
- Cancer Research 165
- Oncology 262
- Pulmonary and Respiratory Medicine 122
- Genetics 112
- Obstetrics and Gynecology 15
Countries citing papers authored by Irene Thiel
This map shows the geographic impact of Irene Thiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irene Thiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irene Thiel more than expected).
Fields of papers citing papers by Irene Thiel
This network shows the impact of papers produced by Irene Thiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irene Thiel. The network helps show where Irene Thiel may publish in the future.
Co-authors
The 7 scholars most cited alongside Irene Thiel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 321 |
| 2 | 2002 | 120 | |
| 3 | 2017 | 87 | |
| 4 | 2002 | 2 | |
| 5 | 2002 | 1 | |
| 6 | Proxy-Ratings versus Self-Ratings in Assessing the Quality of Life of Women with Gynecological Cancer | 2003 | 1 |
| 7 | 1996 | 0 | |
| 8 | 2009 | 0 |
About Irene Thiel
Irene Thiel is a scholar working on Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine, Hematology and Cancer Research, having authored 8 papers that have together received 532 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (2 papers), Cancer survivorship and care (2 papers), Sarcoma Diagnosis and Treatment (1 paper), BRCA gene mutations in cancer (1 paper), Family Support in Illness (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper), Metastasis and carcinoma case studies (1 paper) and Mechanisms of cancer metastasis (1 paper). The work is most often cited by research in Cancer Research (165 citations), Oncology (262 citations), Pulmonary and Respiratory Medicine (122 citations), Genetics (112 citations) and Obstetrics and Gynecology (15 citations). Irene Thiel has collaborated with scholars based in Austria. Frequent co-authors include Florentia Peintinger, Elfriede Greimel, Edgar Petru, Herman Einsele, Carsten Bokemeyer, Lothar Kanz and Hans‐Joachim Schmoll. Their work appears in journals such as International Journal of Gynecological Cancer, Annals of Oncology, The Lancet Oncology, Oncology Reports and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.